U.S. Patent and Trademark Office Publishes Novmetapharma Co Ltd, Seoul National University Hospital and Seoul National University R&DB Foundation's Patent Application for Use of Cyclo(His-Pro) (CHP) for Preventing, Ameliorating, or Treating Fibrosis

Press/Media: Press / Media

Period2022 Jul 2

Media coverage

1

Media coverage

  • TitleU.S. Patent and Trademark Office Publishes Novmetapharma Co Ltd, Seoul National University Hospital and Seoul National University R&DB Foundation's Patent Application for Use of Cyclo(His-Pro) (CHP) for Preventing, Ameliorating, or Treating Fibrosis
    Media name/outletGLOPRM
    Country/TerritoryUnited States
    Date22/7/2
    PersonsSu Houng Lee